Abstract
There is increasing concern that contraceptive pill usage may increase the risk of hepatocellular carcinoma. As primary malignant liver cancer is very rare in this country, any effect due to oral contraceptives should be apparent in national mortality statistics. An analysis of mortality rates over the last 24 years shows a small but consistent increase for young women starting to occur during the end of the last decade. However no such trend is apparent in data from other countries where pill usage is comparable to that in the U.K. Overall liver cancer remains an extremely uncommon cause of death in developed countries, but it will be particularly important to monitor trends in this disease in the future.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Forman, D., Doll, R. & Peto, R. Trends in mortality from carcinoma of the liver and the use of oral contraceptives. Br J Cancer 48, 349–354 (1983). https://doi.org/10.1038/bjc.1983.199
Issue Date:
DOI: https://doi.org/10.1038/bjc.1983.199
This article is cited by
-
Hepatobiliary complications of oral contraceptives
Journal of General Internal Medicine (1992)
-
�thinyloestradiol und Hepatocarcinogenese. Eine experimentelle Beobachtung
Langenbecks Archiv f�r Chirurgie (1987)
-
The epidemiology of primary liver cancer in a West German population: the Saarland
Journal of Cancer Research and Clinical Oncology (1986)